Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Russell E Ware

Showing results (261-270 of 267) with videos related to

Pageof 27
Sort By:
You have reached the last page of results.This site can display upto 267 results.
Blood Advances|October 20, 2022
The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodologyNancy S Green, Andrew Zapfel, Obiageli E Nnodu, et al.
Lancet (London, England)|May 17, 2011
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Winfred C Wang, Russell E Ware, Scott T Miller, et al.
Vaccine|May 27, 2023
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccinationZhao-Hua Zhou, Margaret M Cortese, Jia-Long Fang, et al.
Plos One|July 14, 2021
Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020Greg Davis, Allen J York, Willis Clark Bacon, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
JMIR Research Protocols|May 21, 2021
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled TrialAnna M Hood, Heather Strong, Cara Nwankwo, et al.
Lancet (London, England)|December 17, 2015
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E Ware, Barry R Davis, William H Schultz, et al.
Pageof 27

Showing results (261-270 of 267) with videos related to

Sort By:
Pageof 27
You have reached the last page of results.This site can display upto 267 results.
Blood Advances|October 20, 2022
The Consortium on Newborn Screening in Africa for sickle cell disease: study rationale and methodologyNancy S Green, Andrew Zapfel, Obiageli E Nnodu, et al.
Lancet (London, England)|May 17, 2011
Hydroxycarbamide in very young children with sickle-cell anaemia: a multicentre, randomised, controlled trial (BABY HUG)Winfred C Wang, Russell E Ware, Scott T Miller, et al.
Vaccine|May 27, 2023
Evaluation of association of anti-PEG antibodies with anaphylaxis after mRNA COVID-19 vaccinationZhao-Hua Zhou, Margaret M Cortese, Jia-Long Fang, et al.
Plos One|July 14, 2021
Seroprevalence of SARS-CoV-2 infection in Cincinnati Ohio USA from August to December 2020Greg Davis, Allen J York, Willis Clark Bacon, et al.
The Lancet. Haematology|July 14, 2023
Defining global strategies to improve outcomes in sickle cell disease: a Lancet Haematology CommissionFrédéric B Piel, David C Rees, Michael R DeBaun, et al.
JMIR Research Protocols|May 21, 2021
Engaging Caregivers and Providers of Children With Sickle Cell Anemia in Shared Decision Making for Hydroxyurea: Protocol for a Multicenter Randomized Controlled TrialAnna M Hood, Heather Strong, Cara Nwankwo, et al.
Lancet (London, England)|December 17, 2015
Hydroxycarbamide versus chronic transfusion for maintenance of transcranial doppler flow velocities in children with sickle cell anaemia-TCD With Transfusions Changing to Hydroxyurea (TWiTCH): a multicentre, open-label, phase 3, non-inferiority trialRussell E Ware, Barry R Davis, William H Schultz, et al.
Pageof 27